Source: Journal of Clinical Psychopharmacology. Unidades: IME, FM
Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA), CO-TERAPIA, FÁRMACOS SINTÉTICOS, ANTIPSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Juliana Belo et al. A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, v. 31, n. 6, p. 763-768, 2011Tradução . . Disponível em: https://doi.org/10.1097/JCP.0b013e3182367aee. Acesso em: 15 nov. 2024.APA
Diniz, J. B., Shavitt, R. G., Fossaluza, V., Koran, L., Pereira, C. A. de B., & Miguel, E. C. (2011). A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, 31( 6), 763-768. doi:10.1097/JCP.0b013e3182367aeeNLM
Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CA de B, Miguel EC. A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder [Internet]. Journal of Clinical Psychopharmacology. 2011 ; 31( 6): 763-768.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1097/JCP.0b013e3182367aeeVancouver
Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CA de B, Miguel EC. A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder [Internet]. Journal of Clinical Psychopharmacology. 2011 ; 31( 6): 763-768.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1097/JCP.0b013e3182367aee